Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Yale University · National Institutes of Health
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
887
total citations
- FWCI
- 23.24
- Percentile
- 100%
- References
- 187
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- Glutamatergic
- Monoaminergic
- Mood disorders
- Serotonergic
- Neuroscience
- Mood
- Dopaminergic
- Medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.